14-day Premium Trial Subscription Try For FreeTry Free

Inovio Pharmaceuticals (INO) Reports Q4 Loss, Tops Revenue Estimates

11:05pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
Inovio (INO) delivered earnings and revenue surprises of -51.52% and 301.44%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Inovio Pharmaceuticals'' (INO) Q4 2021 results missed on the bottom line as its net loss significantly widened.
Inovio Pharmaceuticals, Inc. (INO) CEO Dr. Joseph Kim on Q4 2021 Results - Earnings Call Transcript
Inovio Pharmaceuticals press release (INO): FY GAAP EPS of -$1.45 misses by $0.19.Revenue of $1.77M (-76.1% Y/Y) beats by $0.31M.Shares -5.56%.As of December 31, 2021, cash and…

2 Money-Burning Biotech Stocks to Avoid

01:45pm, Tuesday, 01'st Mar 2022 The Motley Fool
These companies have taken a beating, and there's no relief on the horizon.
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine, Inc. (NASDAQ: EDIT) sai

Can Inovio Pharmaceuticals Q4 results bring earnings surprise?

05:20pm, Monday, 28'th Feb 2022 Seeking Alpha
Inovio Pharmaceuticals (NASDAQ:INO) is scheduled to announce Q4 earnings results on Tuesday, March 1st, after market close.The consensus EPS Estimate is -$0.32 (-128.6% Y/Y) and…
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) with the stream of -0.31% also noticed, India Alcoa Corporation (NYSE:AA) encountered a rapid change of 6.21% in the last hour of trading session. Inovio Pharmaceuticals, … The post Stock Runner: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Alcoa Corporation (NYSE:AA) appeared first on Stocks Equity .
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends. Here are the latest analyst rating updates for AMC Entertainment Holdings Inc (NYSE: AMC ), Romeo Power Inc (NYSE: RMO ) and Inovio Pharmaceuticals Inc (NASDAQ: INO ): The latest price target for AMC was by Wedbush on Nov. 4. The analyst firm set a price target … Full story available on Benzinga.com

This Trend Is the Biggest Risk to Biotech Investors Right Now

04:45pm, Monday, 21'st Feb 2022 The Motley Fool
Wall Street seems to have a grudge against the entire sector at the moment.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) with the stream of -1.85% also noticed, India Teva Pharmaceutical Industries Limited (NYSE:TEVA) encountered a rapid change of -2.04% in the last hour of Fridays trading The post Stocks Volume Buzz: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Teva Pharmaceutical Industries Limited (NYSE:TEVA) appeared first on Stocks Equity .

Alkermes (ALKS) Q4 Earnings and Revenues Beat Estimates

01:55pm, Wednesday, 16'th Feb 2022 Zacks Investment Research
Alkermes (ALKS) delivered earnings and revenue surprises of 76.92% and 1.44%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Molina Healthcare (MOH) Q4 Earnings Beat on Higher Premiums

05:05pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Molina Healthcare (MOH) expects its 2022 business to witness reduced impacts from COVID. Strong Medicare and Medicaid performance is set to buoy results.

Humana (HUM) Q4 Earnings Beat Estimates on Membership Growth

05:43pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
Humana (HUM) is taking multiple initiatives like cost savings and others to generate $1 billion additional value to fund the Medicare Advantage business and boost Healthcare Services capabilities.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE